A study from Yale University today in JAMA Network Open reveals substantial protection by the preventive drug nirsevimab (Beyfortus) against infant respiratory syncytial virus (RSV) infections, ...
From next Monday, 17 March, free immunisation from respiratory syncytial virus (RSV) will be available to all newborn babies.
Sanofi joins force with Samitivej International Children’s Hospital to launch the “Together Against RSV” awareness campaign in Thailand, with the support from the Pediatric Infectious Disease Society ...
From next Monday, 17 March, free immunisation from respiratory syncytial virus (RSV) will be available to all newborn babies.It will mean all newborn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback